Latest in News & Research
Does Dupilumab Provide Sustained Control of Atopic Dermatitis?
Dupilumab can help patients achieve adequate disease control and reduce use of other therapies
By Dermsquared Editorial Team | | December 15, 2021
COVID-19 Severity Does Not Differ for Patients With Skin Conditions
Acute COVID-19 and its treatment can impact the course of skin disease in vitiligo, psoriasis, atopic dermatitis, chronic urticaria
By Physician’s Briefing Staff | | December 15, 2021
Report Highlights Characteristics of Omicron SARS-CoV-2 Variant in U.S.
Fourteen of the first 43 cases reported international travel during the 14 days preceding symptom onset or positive test result
By Physician’s Briefing Staff | | December 14, 2021
Omicron Resists Pfizer Vaccine but Causes Less Severe Disease
Risk for hospital admission among adults with COVID-19 29 percent lower than in the first pandemic wave that began in March 2020
By Physician’s Briefing Staff | | December 14, 2021
Adjuvant Dupilumab Improves Asthma Control for Children
Adding dupilumab versus placebo reduced exacerbations, improved lung function in children with uncontrolled moderate-to-severe asthma
By Physician’s Briefing Staff | | December 09, 2021
Topical Tapinarof Reduces Severity of Plaque Psoriasis
Response rate higher but more adverse events seen at week 12 in patients with plaque psoriasis receiving tapinarof versus vehicle control
By Physician’s Briefing Staff | | December 09, 2021
What Are the Consequences of Delay in MMS for Keratinocyte Carcinoma?
22 percent of patients who had delay to MMS due to stay-at-home order were more worried about their cancer
By Dermsquared Editorial Team | | December 08, 2021
Generalized Pustular Psoriasis Is Rare, Has Variable Treatment
More than 20 therapies were tried in a case series of 95 patients; 19 percent reported hospitalization during follow-up
By Dermsquared Editorial Team | | December 08, 2021
Treatments Explored for Moderate-to-Severe Alopecia Areata
Improvement in lesional scalp transcriptome toward nonlesional profile seen at week 24 for both ritlecitinib, brepocitinib
By Physician’s Briefing Staff | | December 08, 2021
Psoriasis Ups Risk for Vascular Disease, Venous Thromboembolism
Risk particularly high in women and individuals with psoriatic arthritis
By Physician’s Briefing Staff | | December 07, 2021
Spatial Clustering of Exemptions Linked to Measles Outbreaks
Increases in medical exemptions result in more than twice as many infections than if exemptions were maintained at pre-policy change level
By Physician’s Briefing Staff | | December 06, 2021
Telemedicine Visits Do Not Lead to More Follow-Up Care
However, telemedicine visits associated with fewer medication prescriptions, orders for laboratory tests or imaging
By Physician’s Briefing Staff | | December 03, 2021
Recommendations Developed for Dermatology Artificial Intelligence
Checklist for evaluation of image-based AI reports grouped into topics of data, technique, technical assessment, application
By Dermsquared Editorial Team | | December 01, 2021
Is BF-200 ALA Superior to Vehicle for Total Lesion Clearance in AK?
BF-200 ALA has high efficacy, excellent cosmetic outcome for patients with mild-to-severe actinic keratoses located on extremities, trunk, neck
By Dermsquared Editorial Team | | December 01, 2021
Giving Nivolumab/Ipilimumab First Ups Overall Survival in Melanoma
Two-year overall survival 72 percent for those starting with N/I, 52 percent for those starting with dabrafenib/trametinib
By Physician's Briefing Staff | | December 01, 2021
Old Spice, Secret Antiperspirants Recalled Due to Benzene
Proctor & Gamble said that it has not received any reports of harm from the recalled products
By Robert Preidt (HealthDay News) | | November 30, 2021
Colorectal Cancer Risk Up for Patients With Psoriasis
In subgroup analysis according to sex, increased risk for CRC seen for female, but not male psoriasis patients
By Physician’s Briefing Staff | | November 30, 2021
Vaccine Makers Already Testing Their Shots Against Omicron Variant
So far, existing vaccines have proven effective against prior coronavirus variants, including the delta variant
By Robin Foster and Robert Preidt (HealthDay News) | | November 29, 2021
Personal Care Product-Related Contact Dermatitis Increasing
Men twice as likely to have soaps as source of PCP, while hair care products were twice as likely to be a source among...
By Dermsquared Editorial Team | | November 24, 2021
Is Patient-Led Surveillance Feasible After Localized Melanoma?
Patient-led surveillance correlated with increased skin self-examination frequency, had no adverse impact on psychological outcomes
By Dermsquared Editorial Team | | November 24, 2021
Pandemic Had Greater Effect on Work-Life Balance for Female Physicians
A sizable gender gap evident for risk of depression and anxiety
By Physician’s Briefing Staff | | November 24, 2021
Risk for Psoriasis Reduced After Tonsillectomy
Among patients with rheumatoid arthritis, the risk for psoriasis was increased after tonsillectomy
By Physician’s Briefing Staff | | November 24, 2021
Atopic Dermatitis Linked to Shorter Stature in Early Childhood
Associations of atopic dermatitis with height and BMI decreased by age 14 and 5.5 years, respectively
By Physician’s Briefing Staff | | November 18, 2021
24 of 1200
Headline from the Week of February 09 - 15, 2026
Second Annual National Cancer Database Report Presented for 2022
By Elana Gotkine (HealthDay News) | | February 11, 2026
Presurgical Pembrolizumab Beneficial for Desmoplastic Melanoma
By Elana Gotkine (HealthDay News) | | February 11, 2026